Viroblock SA Information

Viroblock is a Geneva-based company founded in October 2005 with the goal of developing and commercializing a new generation of antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, such as human and avian influenzas, SARS virus and the AIDS virus. Given their particular antiviral mechanism, Viroblock’s products have a broad spectrum of action across virus families and do not lead to viral resistance.

Website	https://www.viroblock.com
Revenue	$405000
Employees	2 (0 on RocketReach)
Founded	2006
Address	Chemin Des Aulx 18, Plan-Les-Ouates, Plan-les-Ouates, Geneva 1228, CH
Phone	+41 22 884 83 46
Technologies	JavaScript , HTML , PHP +38 more (view full list)
Industry	Health, Wellness and Fitness, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Fitness, Sports, Health Care, Medical, Personal Health
Keywords	Antiviral Products, Drug Discovery, Antiviral Drug Development, Virus Protection, Infection Prevention, Public Health, Biotechnology, Pharmaceutical Research, Health Technology, Virus Research, Disease Prevention, Medical Technology, Viral Diagnostics, Infection Control
Competitors	Johnson & Johnson, Roche, Merck & Co., Inc., Pfizer, GSK, Sanofi, Bayer, AstraZeneca, Moderna Therapeutics, Novavax +41 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies
NAICS	NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies